Regeneron aims for FDA approval of extended dosing for EYLEA HD in AMD and DME, with a decision by April 2025. Pre-filled syringes of high-dose aflibercept are expected to launch by mid-2025, pending ...

Micro-dosing' Ozempic might work for some, but a doctor has warned that some risks come with it. Ozempic has been a topic of discussion for some time now in light of people's weight loss results from ...

Our findings suggest that adults more commonly use droppers, dosing cups, and teaspoons when administering liquid medication to children. The use of more accurate measuring devices might increase ...

The trial in 1,420 adult patients aged 18 to 55 will include dosing with the partners' existing Comirnaty mRNA-based vaccine with the Omicron-based jab in a mix-and-match approach that will be ...

Roche has stopped dosing in a phase 3 trial of tominersen, a potential Huntington’s disease (HD) drug developed with Ionis, after a pre-planned review by independent experts. The companies had ...

Although 80 mg per day is a commonly accepted maximum, dosing up to 200 mg per day has been used safely and effectively. A baclofen withdrawal syndrome can occur with rapid cessation of usage.

Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies Radiance BioPharma Tue, Apr 15, 2025, 2:27 PM 2 ...

The Forsyth Methodist Church Caring for Kids appealed the Georgia Department of Early Care and Learning's (DECAL) decision to revoke its license following an investigation into staff members dosing ...

Objectives: The aim of the study was to analyze glucocorticoid (GC) dosing protocols in dogs with hypoadrenocorticism (HA), and to identify predictors for optimal clinical outcomes during both the ...

La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development. La Merie Publishing offers an e-mail notification service about the release of new products ...

ATLANTA, April 11, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on developing new medicines to ...